Arlene Tieng

NPI: 1184872525
Total Payments
$83,727
2024 Payments
$885.63
Companies
18
Transactions
573
Medicare Patients
139
Medicare Billing
$15,794

Payment Breakdown by Category

Other$39,499 (47.2%)
Consulting$21,135 (25.2%)
Food & Beverage$13,886 (16.6%)
Travel$9,153 (10.9%)
Education$54.35 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $39,499 22 47.2%
Consulting Fee $21,135 4 25.2%
Food and Beverage $13,886 515 16.6%
Travel and Lodging $9,153 25 10.9%
Education $54.35 7 0.1%

Top Paying Companies

Company Total Records Latest Year
AbbVie Inc. $43,121 65 $0 (2023)
Janssen Scientific Affairs, LLC $15,840 2 $0 (2022)
Regeneron Healthcare Solutions, Inc. $9,352 34 $0 (2020)
GENZYME CORPORATION $3,580 13 $0 (2021)
PFIZER INC. $3,578 192 $0 (2024)
Amgen Inc. $3,491 161 $0 (2024)
UCB, Inc. $2,160 32 $0 (2023)
Celgene Corporation $685.46 21 $0 (2019)
E.R. Squibb & Sons, L.L.C. $422.03 6 $0 (2018)
Horizon Therapeutics plc $340.95 8 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $885.63 40 Amgen Inc. ($579.83)
2023 $5,779 60 AbbVie Inc. ($4,738)
2022 $17,069 66 Janssen Scientific Affairs, LLC ($15,840)
2021 $2,040 84 PFIZER INC. ($837.17)
2020 $4,955 62 AbbVie Inc. ($2,172)
2019 $13,440 76 AbbVie, Inc. ($12,266)
2018 $13,739 89 AbbVie, Inc. ($7,862)
2017 $25,820 96 AbbVie, Inc. ($16,083)

All Payment Transactions

573 individual payment records from CMS Open Payments — Page 1 of 23

Date Company Product Nature Form Amount Type
12/06/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $9.05 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/25/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $14.65 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/13/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $14.97 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/07/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $10.34 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/23/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $16.82 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/09/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $6.39 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/09/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $3.88 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/04/2024 Lilly USA, LLC TALTZ (Drug) Food and Beverage In-kind items and services $16.59 General
Category: Immunology
10/01/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $4.60 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
09/19/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $150.00 General
Category: Inflammation/Rare Disease
09/18/2024 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $14.07 General
Category: IMMUNOLOGY
09/10/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $25.37 General
Category: Inflammation/Rare Disease
09/04/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $12.48 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
08/30/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $9.56 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
08/21/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $16.46 General
Category: Inflammation/Rare Disease
07/23/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $150.00 General
Category: Inflammation/Rare Disease
07/19/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $12.60 General
Category: Inflammation/Rare Disease
07/19/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $7.23 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
07/15/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $9.10 General
Category: Inflammation/Rare Disease
07/06/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $9.40 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
06/28/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $8.81 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
06/20/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $16.77 General
Category: Inflammation/Rare Disease
06/13/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $4.24 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
06/06/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $124.12 General
Category: Inflammation
05/17/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $8.95 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 32 44 $12,025 $3,441
2022 1 26 38 $10,982 $3,007
2021 1 26 60 $17,738 $5,243
2020 3 55 70 $14,630 $4,102
Total Patients
139
Total Services
212
Medicare Billing
$15,794
Procedure Codes
7

All Medicare Procedures & Services

7 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 19 31 $8,814 $2,437 27.7%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2023 13 13 $3,211 $1,004 31.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 26 38 $10,982 $3,007 27.4%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 26 60 $17,738 $5,243 29.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 20 30 $7,020 $2,037 29.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 22 27 $4,131 $1,118 27.1%
99203 New patient office or other outpatient visit, typically 30 minutes Facility 2020 13 13 $3,479 $947.30 27.2%

About Arlene Tieng

Arlene Tieng is a Rheumatology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/27/2008. The National Provider Identifier (NPI) number assigned to this provider is 1184872525.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Arlene Tieng has received a total of $83,727 in payments from pharmaceutical and medical device companies, with $885.63 received in 2024. These payments were reported across 573 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($39,499).

As a Medicare-enrolled provider, Tieng has provided services to 139 Medicare beneficiaries, totaling 212 services with total Medicare billing of $15,794. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.

Practice Information

  • Specialty Rheumatology
  • Location Bronx, NY
  • Active Since 08/27/2008
  • Last Updated 03/13/2015
  • Taxonomy Code 207RR0500X
  • Entity Type Individual
  • NPI Number 1184872525

Products in Payments

  • Humira (Biological) $23,736
  • KEVZARA SARILUMAB INJECTION (Biological) $9,191
  • RINVOQ (Biological) $4,738
  • XELJANZ (Drug) $3,578
  • KEVZARA (Drug) $3,531
  • Enbrel (Biological) $2,669
  • KRYSTEXXA (Biological) $796.66
  • Cimzia (Drug) $667.03
  • Otezla (Drug) $632.46
  • KEVZARA (Biological) $284.64
  • Zilretta (Drug) $245.19
  • ACTHAR (Biological) $201.74
  • ORENCIA (Biological) $177.55
  • BENLYSTA (Biological) $172.17
  • TALTZ (Drug) $168.32
  • TAVNEOS (Drug) $124.12
  • NUCALA (Biological) $108.36
  • COSENTYX (Biological) $90.13
  • ZOHYDRO ER (Drug) $54.20
  • HUMIRA (Biological) $39.33

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Rheumatology Doctors in Bronx